These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. "Therapeutic intent" in phase 1 oncology trials: a justifiable objective. Markman M Arch Intern Med; 2006 Jul; 166(14):1446-8. PubMed ID: 16864753 [No Abstract] [Full Text] [Related]
27. [Chemotherapy of endometrial carcinoma]. Grella P Minerva Ginecol; 1976 Apr; 28(4):318-23. PubMed ID: 995322 [No Abstract] [Full Text] [Related]
28. Positive surgical margins: the argument for androgen deprivation and chemotherapy. Higano CS Urol Oncol; 2009; 27(1):89-91. PubMed ID: 19111806 [TBL] [Abstract][Full Text] [Related]
29. A preliminary result of concurrent chemoradiation with weekly cisplatin in elderly nasopharyngeal carcinoma patients. Ho HC; Su YC; Lee MS; Hsiao SH; Hwang JH; Lee CC; Hung SK Acta Otolaryngol; 2008 Aug; 128(8):930-5. PubMed ID: 18607921 [TBL] [Abstract][Full Text] [Related]
30. Does HER2 immunoreactivity provide prognostic information in locally advanced urothelial carcinoma patients receiving adjuvant M-VEC chemotherapy? Tsai YS; Tzai TS; Chow NH Urol Int; 2007; 79(3):210-6. PubMed ID: 17940352 [TBL] [Abstract][Full Text] [Related]
31. Breast cancer in elderly women. Optimizing the treatment. Gennari R; Audisio RA Breast Cancer Res Treat; 2008 Jul; 110(2):199-209. PubMed ID: 17851758 [TBL] [Abstract][Full Text] [Related]
32. Reducing the risk of distant metastases: a better end point in adjuvant aromatase inhibitor breast cancer trials? Tang SC Cancer Invest; 2008 Jun; 26(5):481-90. PubMed ID: 18568770 [TBL] [Abstract][Full Text] [Related]
33. Carboplatin and paclitaxel adjuvant chemotherapy in primitive neuroectodermal tumor of the uterine corpus. Shah JP; Jelsema J; Bryant CS; Ali-Fehmi R; Malone JM Am J Obstet Gynecol; 2009 Feb; 200(2):e6-9. PubMed ID: 19110219 [TBL] [Abstract][Full Text] [Related]
34. Early-stage NSCLC: the role of radiotherapy and systemic therapy. Bunn PA J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S31-40. PubMed ID: 19780244 [TBL] [Abstract][Full Text] [Related]
35. [Polychemotherapy in the treatment of genital sarcomata (author's transl)]. Ptácková B; Kucera F Cesk Gynekol; 1976 Dec; 41(10):739-40. PubMed ID: 1009610 [No Abstract] [Full Text] [Related]
36. Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001. Koivisto-Korander R; Butzow R; Koivisto AM; Leminen A Gynecol Oncol; 2008 Oct; 111(1):74-81. PubMed ID: 18657852 [TBL] [Abstract][Full Text] [Related]
37. Adjuvant therapy of colon cancer: current status and future directions. Chung KY; Saltz LB Cancer J; 2007; 13(3):192-7. PubMed ID: 17620769 [TBL] [Abstract][Full Text] [Related]
38. The potential risk of neoadjuvant chemotherapy in breast cancer patients--results from a prospective randomized trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-07). Taucher S; Steger GG; Jakesz R; Tausch C; Wette V; Schippinger W; Kwasny W; Reiner G; Greil R; Dubsky P; Poestlberger S; Tschmelitsch J; Samonigg H; Gnant M; Breast Cancer Res Treat; 2008 Nov; 112(2):309-16. PubMed ID: 18080748 [TBL] [Abstract][Full Text] [Related]
39. Adjuvant chemotherapy for primary breast cancer. Fornier M; Hudis C Curr Oncol Rep; 2005 Jan; 7(1):18-22. PubMed ID: 15610682 [TBL] [Abstract][Full Text] [Related]
40. Treatment of metastatic renal cell carcinoma. Reeves DJ; Liu CY Cancer Chemother Pharmacol; 2009 Jun; 64(1):11-25. PubMed ID: 19343348 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]